Study Finds FlexPro MD® Formulation Reduces Joint Pain, Inflammation in Osteoarthritis Model

New Study Validates FlexProMD’s Contribution To Mobility and Quality of Life
Nutrients, a well-respected, peer-review professional journal, published a study that finds ingredients in Valensa’s FlexProMD® reduces joint pain and inflammation in an osteoarthritis-induced model. The study builds on existing research that shows that FlexProMD® is three times more effective at relieving joint discomfort than glucosamine and chondroitin. Ask us how to incorporate this natural formulation into your product line.

Read More »

What USP Means to USPlus® Saw Palmetto and Parry™ Organic Spirulina

A new infographic explains how USP verification builds accountability and trust. The United States Pharmacopeia (USP) helps regulate the dietary supplement industry, which provides a third-party auditing service that reviews, tests and monitors the potency and purity of the brand and related products seeking authenticity. For Valensa International, both the USPlus® Pure Saw Palmetto extract, and […]

Read More »

United States Pharmacopeia Renews Verified Status for First and Only Saw Palmetto for Valensa’s USPlus®

USPlus® Saw Palmetto, which supports prostate health, successfully completes annual surveillance by USP’s Ingredient Verification Program for Dietary Ingredients, reflecting adherence to Good Manufacturing Practices (GMP) and recognized quality standards. ORLANDO, Fla. (April 7, 2020) — Valensa International, a leading provider of Fresh from Florida™ saw palmetto extract, announced today that the company’s USPlus® Saw […]

Read More »

Valensa’s Supply Chain Gives Confidence in Continuity

Valensa’s Integrated Supply Chain Capabilities for Continuity of Your Business For Valensa, the value of investing in a fully integrated supply chain begins with ownership of our astaxanthin production facility in South America and the partnership with our sister company in India for spirulina, chlorella and phycocyanin supply. We go beyond ownership of production to […]

Read More »

Letter from the CEO

RE: Supply Chain Excellence To Count On Dear Wellness Colleague: Like you, we here at Valensa International are focused on the global health issue, and understand your concerns around business disruption. For decades, you’ve trusted us to deliver the highest quality nutraceuticals. I want to assure you that our long-standing commitment to supply chain excellence allows us to sustain production and inventories across our portfolio, even in uncertain times, to support your business […]

Read More »

New Science Cushions Joint Health Challenge

Margaret H. Dohnalek, Chief Science Officer, Valensa, reports that living an active lifestyle is possible, although challenging, as the human body ages, battling factors such as oxidative stress, inflammation and weakening bones. Read More.

Read More »

Valensa Innovates, Educates at SupplySide West 2019; USP Panel

Valensa International introduced a new innovation, while educating the industry about achieving US Pharmacopeia Dietary Ingredient Verification Program (USP DIVP) status during a first-time panel discussion at the SupplySide West exhibition in Las Vegas, October 15-19. During the convention, which attracted an estimated 30,000 people from the industry, Valensa introduced a new form of Zanthin® […]

Read More »

Zanthin® Natural Astaxanthin -Nature’s Powerhouse for Wellness & Healthy Aging

Greatness can come from the smallest things. Some of the smallest plants on earth, algae, can be packed with protein, vitamins and minerals and deliver a big nutritional punch. Learn how Zanthin is the powerhouse from nature for wellness and healthy aging. Read More.

Read More »

Valensa International to Host First-Time Panel Sharing Path to USPlus® Saw Palmetto USP Verification

Panelists feature Valensa saw palmetto quality experts and USP’s Edward Wyszumiala, discussing value of USP verification ORLANDO, Fla. (October 7, 2019) — Faced with adulterated or fake extracts, the Saw Palmetto extract market has been challenged worldwide, straining the trust in the industry and consumers. Yet, scientific research continues to support quality Saw Palmetto extract […]

Read More »

Valensa’s Chief Scientist Presents at First-Time Animal Health Nutraceuticals Event

Margaret Dohnalek, Ph.D., Chief Science Officer at Valensa International, was invited to participate in the first-ever International Conference on Animal Health Nutraceuticals (ICAHN 2019), which highlighted advancements in the rapidly growing field of nutraceuticals and nutritional health for animals. ICAHN 2019 was hosted in conjunction with the University of Wisconsin-Stout (UW-Stout) on July 17-19 at […]

Read More »